Mostafa Ghanei

Tehran (IP)- Iran's Head of Scientific Committee of Coronavirus Combat and Prevention Headquarters announced the exclusive production of COVID-19 antibodies and clinical tests of a coronavirus medicine.

Iran Press/Iran News: Mostafa Ghanei said: "It will take about one to two months to test the stability of the coronavirus antibody, but Iranian researchers have been successful in the early stages of production."

Head of Scientific Committee of Coronavirus Combat and Prevention Headquarters further explained that a combination of three coronavirus drugs is currently being clinically tested.

"Iran is one of five countries that will play an important role in the treatment and diagnosis of the coronavirus over the next three months," Mostafa Ghanei noted. 

The antibody is a protective protein produced by the immune system in response to the presence of an external substance.

Iranian researchers from the early days of Coronavirus outbreak start projects to produce specific immunoglobulin (antibodies) of the coronavirus in the country including plasma-derived therapy..

So far 97,424 people in the country have definitely been infected with the coronavirus, 6,203 people have died due to the virus and 78,422 of total infected people have recovered, according to the Health Ministry of Iran.

According to the Head of Public Relations and Information Center of the Health Ministry, Kianoush Jahanpour 80 percent of infected patients to COVID-19 in Iran have been recovered from the disease.

He also said that the rate of infection and fatalities is declining.

104/205

Read More:

Iran manages Corona crisis at height of sanctions: Health Min.

Rouhani praises Iran's medical staff and producers amid coronavirus pandemic

Coronavirus cases are in decrease: Health Min. Spox